EyePoint Pharmaceuticals
EYPT
EYPT
63 hedge funds and large institutions have $231M invested in EyePoint Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.75% more ownership
Funds ownership: 72.16% → 76.91% (+4.8%)
5% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
63
Holding in Top 10
1
Calls
$3.74M
Puts
$835K
Top Buyers
| 1 | +$10M | |
| 2 | +$3.94M | |
| 3 | +$3.4M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.78M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$2.33M | |
| 3 | -$2.12M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.18M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$873K |